7Bookman MA, Greer BE, Ozols RF. Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs cisplatin and paclitaxel (GOG 158) and an update on GOGO 182-ICON5 [J]. Int J Gynecol Cancer, 2003 ,13(6) :735-740.
8Greimel ER, Bjelic-Radisic V, Pfisterer J, et al. Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with eisplatin/paclitaxel versus carboplatin/paclitaxel[ J ]. J Clin Oncol, 2006 , 24 (4) :579-586.
9Le T, Leis A, Pallwa P, et al. Quality of life evaluations in patients with ovarian cancer during chemotherapy treatment [ J ]. Gynecol Oncol, 2004, 92( 3 ) :839-844.
10Bezjak A, Tu D, Bacon M,et al. Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study [J]. J Clin Oncol, 2004 ,22 ( 22 ) :4595-4603.
3Heintz A P M,Griffiths C T,Trimbos J B.Surgery in Gynecological Oncology[M].Springer Netherlands,2012.
4Jacob L,Bleicher L,Kostev K,et al.Prevalence of depression,anxiety and their risk factors in German women with breast cancer in general and gynecological practices[J].J Cancer Res Clin,2015,doi:10.1007/s00432-015-2048-5.
5Dragomir B I,Fodoreanu L.Correlations between state anxiety and quality of life in metastatic breast cancer patients[J].Rev Med Chir Soc Med Nat Iasi,2013,117(3):610-615.
